These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30972175)

  • 1. Rapamycin inhibits peritoneal fibrosis by modifying lipid homeostasis in the peritoneum.
    Liu J; Jiang CM; Feng Y; Zhu W; Jin B; Xia YY; Zhang QY; Xu PF; Zhang M
    Am J Transl Res; 2019; 11(3):1473-1485. PubMed ID: 30972175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mammalian Target of Rapamycin Complex 1 Activation Disrupts the Low-Density Lipoprotein Receptor Pathway: A Novel Mechanism for Extracellular Matrix Accumulation in Human Peritoneal Mesothelial Cells.
    Liu J; Zhu W; Jiang CM; Feng Y; Xia YY; Zhang QY; Xu PF; Zhang M
    Am J Nephrol; 2018; 48(5):357-368. PubMed ID: 30423569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the RAS contributes to peritoneal fibrosis via dysregulation of low-density lipoprotein receptor.
    Liu J; Feng Y; Li N; Shao QY; Zhang QY; Sun C; Xu PF; Jiang CM
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F273-F284. PubMed ID: 33427062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin inhibits epithelial-to-mesenchymal transition of peritoneal mesothelium cells through regulation of Rho GTPases.
    Xiang S; Li M; Xie X; Xie Z; Zhou Q; Tian Y; Lin W; Zhang X; Jiang H; Shou Z; Chen J
    FEBS J; 2016 Jun; 283(12):2309-25. PubMed ID: 27093550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valsartan ameliorates high glucose-induced peritoneal fibrosis by blocking mTORC1 signaling.
    Liu J; Feng Y; Sun C; Zhu W; Zhang QY; Jin B; Shao QY; Xia YY; Xu PF; Zhang M; Jiang CM
    Exp Biol Med (Maywood); 2020 Jun; 245(11):983-993. PubMed ID: 32408765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfotanshinone IIA Sodium Ameliorates Glucose Peritoneal Dialysis Solution-Induced Human Peritoneal Mesothelial Cell Injury via Suppression of ASK1-P38-mediated Oxidative Stress.
    Zhou Y; He W; Sun W; Zhou Z; Sun M; Xia P; Li W; Zheng M; Zhang L; Ni J; Gao K
    Cell Physiol Biochem; 2018; 46(6):2434-2444. PubMed ID: 29742502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II type 2 receptor prevents extracellular matrix accumulation in human peritoneal mesothelial cell by ameliorating lipid disorder via LOX-1 suppression.
    Liu J; Jin B; Lu J; Feng Y; Li N; Wan C; Zhang QY; Jiang CM
    Ren Fail; 2022 Dec; 44(1):1687-1697. PubMed ID: 36226438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
    Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
    Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory stress exacerbates lipid accumulation in hepatic cells and fatty livers of apolipoprotein E knockout mice.
    Ma KL; Ruan XZ; Powis SH; Chen Y; Moorhead JF; Varghese Z
    Hepatology; 2008 Sep; 48(3):770-81. PubMed ID: 18752326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimethylaminomicheliolide ameliorates peritoneal fibrosis through the activation of autophagy.
    Li S; Peng F; Gong W; Wu J; Wang Y; Xu Z; Liu W; Li H; Yin B; Zhang Y; Chen S; Luo C; Li P; Chen Y; Huang Q; Zhou W; Long H
    J Mol Med (Berl); 2019 May; 97(5):659-674. PubMed ID: 30854581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone inhibits high glucose-induced synthesis of extracellular matrix by NF-κB and AP-1 pathways in rat peritoneal mesothelial cells.
    Zhou G; Su X; Ma J; Wang L; Li D
    Mol Med Rep; 2013 Apr; 7(4):1336-42. PubMed ID: 23404530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragalus Total Saponins Ameliorate Peritoneal Fibrosis by Promoting Mitochondrial Synthesis and Inhibiting Apoptosis.
    Li ZH; Xu R; Shi J; Yu MS; Zhong Y; He WM; Cao LP; Sheng MX
    Am J Chin Med; 2022; 50(1):261-274. PubMed ID: 34983328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A selective cyclooxygenase-2 inhibitor decreases transforming growth factor-beta1 synthesis and matrix production in human peritoneal mesothelial cells.
    Liu H; Peng Y; Liu F; Li J; Chen X; Liu Y; Zhang H
    Cell Biol Int; 2007 May; 31(5):508-15. PubMed ID: 17196403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Toll-like receptors with soluble Toll-like receptor 2 prevents peritoneal dialysis solution-induced fibrosis.
    Raby AC; González-Mateo GT; Williams A; Topley N; Fraser D; López-Cabrera M; Labéta MO
    Kidney Int; 2018 Aug; 94(2):346-362. PubMed ID: 29861057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telmisartan attenuates peritoneal fibrosis via peroxisome proliferator-activated receptor-γ activation in rats.
    Su X; Yu R; Yang X; Zhou G; Wang Y; Li L; Li D
    Clin Exp Pharmacol Physiol; 2015 Jun; 42(6):671-9. PubMed ID: 25867712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diltiazem suppresses collagen synthesis and IL-1beta-induced TGF-beta1 production on human peritoneal mesothelial cells.
    Fang CC; Yen CJ; Chen YM; Chu TS; Lin MT; Yang JY; Tsai TJ
    Nephrol Dial Transplant; 2006 May; 21(5):1340-7. PubMed ID: 16421162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc supplementation inhibits the high glucose‑induced EMT of peritoneal mesothelial cells by activating the Nrf2 antioxidant pathway.
    Gao L; Fan Y; Zhang X; Yang L; Huang W; Hang T; Li M; Du S; Ma J
    Mol Med Rep; 2019 Jul; 20(1):655-663. PubMed ID: 31115566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HL156A, a novel AMP-activated protein kinase activator, is protective against peritoneal fibrosis in an in vivo and in vitro model of peritoneal fibrosis.
    Ju KD; Kim HJ; Tsogbadrakh B; Lee J; Ryu H; Cho EJ; Hwang YH; Kim K; Yang J; Ahn C; Oh KH
    Am J Physiol Renal Physiol; 2016 Mar; 310(5):F342-50. PubMed ID: 26661649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pathogenetic role for M1 macrophages in peritoneal dialysis-associated fibrosis.
    Li Q; Zheng M; Liu Y; Sun W; Shi J; Ni J; Wang Q
    Mol Immunol; 2018 Feb; 94():131-139. PubMed ID: 29306153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valsartan decreases TGF-β1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats.
    Subeq YM; Ke CY; Lin NT; Lee CJ; Chiu YH; Hsu BG
    Cytokine; 2011 Feb; 53(2):223-30. PubMed ID: 21129996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.